Clinical Trial Update: Efficacy of OnabotulinumtoxinA in Migraine [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy of onabotulinumtoxinA for migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation | Conditions: Migraine | Phase 2 | Status: COMPLETED